S100A8 and S100A9 in hematologic Malignancies: from development to therapy

F Razmkhah, S Kim, S Lim, AJ Dania… - International journal of …, 2023 - mdpi.com
S100A8 and S100A9 are multifunctional proteins that can initiate various signaling
pathways and modulate cell function both inside and outside immune cells, depending on …

Fatty liver index (FLI): more than a marker of hepatic steatosis

AM Kaneva, ER Bojko - Journal of physiology and biochemistry, 2024 - Springer
Fatty liver index (FLI) was developed as a simple and accurate marker of hepatic steatosis.
FLI is derived from an algorithm based on body mass index, waist circumference, and levels …

S-100 proteins: basics and applications as biomarkers in animals with special focus on calgranulins (S100A8, A9, and A12)

JJ Cerón, A Ortín-Bustillo, MJ López-Martínez… - Biology, 2023 - mdpi.com
Simple Summary S100 proteins are a group of calcium-binding proteins which have a
similar molecular mass and share similarities in their amino acid sequence. They are …

Traditional Chinese medicines and natural products targeting immune cells in the treatment of metabolic-related fatty liver disease

Z Li, H Ouyang, J Zhu - Frontiers in Pharmacology, 2023 - frontiersin.org
MAFLD stands for metabolic-related fatty liver disease, which is a prevalent liver disease
affecting one-third of adults worldwide, and is strongly associated with obesity …

Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities

ME Shaker, HAM Gomaa, MA Abdelgawad… - International …, 2023 - Elsevier
Inflammation has been convicted of causing and worsening many liver diseases like acute
liver failure, fibrosis, cirrhosis, fatty liver and liver cancer. Pattern recognition receptors …

Activated carbon for sepsis prevention and intervention: A modern way of utilizing old therapies

E Snezhkova, H Redl, J Grillari, M Osuchowski - C, 2023 - mdpi.com
(1) Background: Uncontrolled inflammation often contributes to life-threatening sepsis
sequela such as multi-organ dysfunction syndrome (MODS), and is accompanied by …

Plasma calprotectin and new-onset type 2 diabetes in the general population: a prospective cohort study

AR Bourgonje, MF Bourgonje, S Sokooti… - The Journal of …, 2024 - academic.oup.com
Context Systemic inflammation plays a pivotal role in the development of type 2 diabetes
(T2D). Objective We hypothesized that circulating levels of calprotectin, a myeloid cell …

Gut microbiota in MAFLD: therapeutic and diagnostic implications

W Alghamdi, M Mosli… - Therapeutic Advances in …, 2024 - journals.sagepub.com
Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as
nonalcoholic fatty liver disease, is becoming a significant contributor to chronic liver disease …

NAFLD/MAFLD: New Evidence

A Mantovani, A Dalbeni - International Journal of Molecular Sciences, 2023 - mdpi.com
The aim of the second edition of our Special Issue, entitled “Nonalcoholic Fatty Liver
Disease/Metabolic Associated Fatty Liver Disease: New Insights 2.0”, is to report the recent …

[HTML][HTML] Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons

M Al-Beltagi, NK Saeed, AS Bediwy… - World Journal of Clinical …, 2024 - wjgnet.com
BACKGROUND Fecal calprotectin is a valuable biomarker for assessing intestinal
inflammation in pediatric gastrointestinal diseases. However, its role, pros, and cons in …